Investors
PepTcell benefits from investments from the following individuals:
• Roderick Bransgrove
• Feroze Janmohamed
• John Hardy
• Donald MacKinnon
• Kimbell Duncan
• James Synge
• Gregory Stoloff
Roderick Bransgrove's original business experience was gained in the pharmaceutical industry, having worked for Schering Chemicals Limited (the UK subsidiary of Schering AG) for 15 years. Rod joined Schering in 1972 and completed a career path through Marketing and Sales Management into General Management. In 1986, he founded Imperial Pharmaceutical Services Limited which merged with Shire Pharmaceuticals Group plc ("Shire") in 1995. From 1995-1998 Rod was a Non-Executive Director of Shire. He is also Chairman of Entertainment Rights plc which is listed on the London Stock Exchange, a company specialising in the exploitation of intellectual property rights and children's television characters. Rod also became Chairman of Rose Bowl plc which incorporated Hampshire Cricket Limited in October 2000. Other Directorships include England and Wales Cricket Board.
Feroze Janmohamed has a pharmaceutical background and currently co invests with Roderick Bransgrove in a number of different investments including medical scientific entities.
John Hardy has a scientific background and a career in film finance and the advisory area of Investment Banks, ultimately being a shareholder in a listed Investment Bank which he was involved in creating. John currently is involved in the provision of complex funding with particular emphasis on structured finance.
Donald MacKinnon has a stockbroking background and currently focuses on complex financings for the retail sector. Donald has previously held other investments in the scientific medical area.
Kimbell Duncan has a scientific background specialising in electrical engineering and has had a career in investment banking where he primarily focused on trading financial instruments. He now focuses on private equity investments in a number of different sectors.